• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Medication Non-Adherence: The Make-It-or-Break-It of Psychopharmacology

Medication Non-Adherence: The Make-It-or-Break-It of Psychopharmacology

December 1, 2013
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
John D. Preston, PsyD, ABPP

Both in general medicine and in psychiatry, the number one cause of treatment failure is not taking medications as prescribed. There are a number of reasons for non-adherence, ranging from physical side effects to psychological issues. Here, we’ll discuss the most common reasons for non-adherence, and some strategies for helping your patients stay on their meds.

Impatience

Many psychotropic medications require weeks of treatment before the first signs of clinical improvement. Many psychiatric disorders, especially depression, result in patients feeling pessimistic and hopeless. Even if they have been told about the need to wait in order to see improvement, after a few days frequently patients conclude that the drug is not working and discontinue the medication. This may be particularly true among adolescents, who want instant gratification. What makes this especially difficult to deal with is that often teens won’t share their feelings and concerns with the treatment provider.

Side Effects

At times, side effects are so intense and unpleasant that they may frighten a patient or greatly concern the parents. A common example is activation (acute onset anxiety) following the first dose of an antidepressant prescribed for depression or an anxiety disorder. Intense anxiety not only may lead to medication discontinuation, but also may leave the patient traumatized by the experience to the point that they decide to never seek psychiatric treatment again.

Often side effects such as weight gain or sexual dysfunction are the cause of patient-initiated discontinuation.

Fears

Worries about adverse medication effects such as addiction are not uncommon, despite not being based on real evidence. These fears often exist not only for patients, but also for their parents.

Another common and very understandable fear is related to the risk of suicide from antidepressants. Antidepressant advertisements on television always state that increased suicidality may occur with antidepressants. Research shows that most antidepressants used in kids, with the exception of venlafaxine (Effexor), have a similar low risk for causing suicide—certainly a lower risk than untreated depression itself.

Psychological Dynamics

The list of possible adherence problems due to psychological issues is long and complex. Here are some of the most common problems encountered in clinical practice.

Feeling of loss of control. The experience of loss of control accompanies many psychiatric disorders. Medication side effects can, at times, exacerbate that experience.

False ideas about prescriber’s goals. The perception that the prescriber sees their problem only from a biological perspective can lead to non-adherence. The patient perceives that a drug may or may not help, but that their personal, emotional issues are ignored.

Desire to remain “sick.” There may be secondary gain from continuing to be sick. This may be conscious or unconsciously motivated. Examples include the young person’s need to induce guilt and punish their parents or how some children learn that they get needed attention and care from their parents when they are sick.

Wanting the doctor to fail. Sometimes defeating the doctor is gratifying. Intentional or not, non-adherence leads to repeated medications failures. Often this dynamic is seen in patients who have a history of significant child abuse. They may sincerely ask for help to reduce painful symptoms. However, the unconscious need to control, punish, or in other ways render the prescriber impotent, may drive non-adherence. This dynamic does not go away unless it is unearthed and explored in therapy.

Being overwhelmed. Some patients truly cannot adequately take in and process what their physicians tell them about medication treatment and what to expect from this treatment. For example, depression alone can cause difficulty with memory owing to decreased capacity for maintaining attention and concentration.

Stigma. Negative stigma regarding mental illnesses persists. Taking a medication is a concrete reminder that, “I have a psychiatric disorder.” This is a significant issue that can lead to non-adherence.

Pressures from family and friends. Finally, messages from close friends and family may undermine treatment. For example, “Hey man, I heard that that drug can make you suicidal,” or “You don’t need medicines; if you just try harder you can pull yourself out of this.”

In some 12-step programs there is pressure put on members to stay away from all “mind altering” drugs, including psychiatric medications. Certainly some classes of drugs do pose real dangers of addiction in those vulnerable to substance abuse; however most classes of psychiatric drugs are not addictive. The impact of these social and interpersonal pressures can be substantial.

How to Combat Non-Adherence

All of these reasons for non-adherence should be kept in mind, especially when a patient isn’t getting better. According to psychiatrist Shawn Shea, patients always weigh the pros and cons of medication they are taking. This often is done in a non-systematic and disorganized way and the decision “to take or not to take” is not shared with their doctors (Shea SC, Improving Medication Adherence: How to Talk with Patients About Their Medications. Lippincott, Williams and Wilkins: Philadelphia; 2006).

So, what to do? When you first prescribe a medication, preemptively bring up the prospect of your patient deciding not to stay on the drug. As you work with your patient, remember to do the following:

  • Consider the pros and cons: Explain the effectiveness of the drug versus side effects and any psychological issues that may lead the patient to want to discontinue. Be proactive and tell patients and parents not to hesitate to bring up any concerns that might arise.

  • Anticipate side effects: Share with the patient, “I’m sure you know that some medications have side effects, and you may experience this. It matters a lot to me to make sure this therapy is effective, so please don’t hesitate to tell me if you encounter any side effects. If you do, we’ll find a way to deal with it.” The weighing of pros and cons is best done in your office where things can be systematically evaluated by both the patient and the clinician.
    When side effects do emerge it is important to evaluate how severe they are. Are they tolerable? Are they disabling or interfering with important life activities? Might the side effects diminish with time?

  • Check in: Periodically ask the patient for an assessment of the medication. Ask, “How well would you say you are doing on the medicine?” Inquire about what family members or a child’s friends are saying about the patient’s medical treatment. This often has a huge impact on medication adherence.
    An important key to good treatment outcomes is to give patients and their parents time to really explore any concerns or worries that they might have about the psychiatric medication being recommended.

    For instance, patients may express fears of addiction if they take an antidepressant. Just giving them information about the drug being non-addictive often is not effective. It is considerably more helpful to explore in some detail with the patient how they feel about it and what they have been told about the drug.


Truly hearing the patient’s concerns is, first and foremost, a decent way to interact with a fellow human being. It also may flesh out worries that have gone unspoken. This kind of thoughtful way to address fears and worries not only helps reduce non-adherence, but it can also contribute to establishing a positive therapeutic alliance.
Child Psychiatry
KEYWORDS child-psychiatry psychopharmacology_tips
    www.thecarlatreport.com
    Issue Date: December 1, 2013
    SUBSCRIBE NOW
    Table Of Contents
    Study Finds Multiple Health Disparities for Transgender Youth
    Positive School Environment Beats Drug Testing for Teens
    Does Early Nonreponse to Medication Predict Long-Term Response?
    What Meds Work for Insomnia in ADHD?
    Childhood Sexual Behavior: What’s Normal and What’s Not
    Medication Non-Adherence: The Make-It-or-Break-It of Psychopharmacology
    Skeptics Unite: The International Critical Psychiatry Network (ICPN)
    Navigating the Child Welfare System from Foster Care to Reunification
    Priapism Warning for Some ADHD Meds
    Exposure Therapy Best for Some Girls’ PTSD
    FDA Okays Blood Test for Developmental Delay/Intellectual Disability
    Death Within Nuclear Family in Childhood Increases Risk of Psychosis
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.